- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Sensei Biothera
Sensei Biotherapeutics, Inc. operates as a clinical-stage immunotherapy company. The Company focuses in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. Sensei Biotherapeutics serves customers in the United States.
Stock Analysis
last close
$2.06
1-mo return
3%
3-mo return
28%
avg daily vol.
40.26T
52-week high
12.37
52-week low
1.45
market cap.
$68M
forward pe
-
annual div.
-
roe
-29.1%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
21.7%
